Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough device" designation.

Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.

The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain implant tech as a world-changing solution for people with vision loss.

Elon Musk has announced that his company Neuralink has received approval for a brain implant called "Blindsight" that will enable the blind to see again.

Elon Musk's brain-chip startup Neuralink announces its experimental implant can restore vision, receives US FDA 'breakthrough device' designation.

ELON Musk’s brain-chip startup Neuralink said on Tuesday (Sep 17) that its experimental implant aimed at restoring vision received the US Food and Drug Administration’s (FDA) “breakthrough device” designation.

Elon Musk’s brain chip firm Neuralink has received “breakthrough device” status for an implant aimed at helping blind patients regain their sight, the firm announced Wednesday. Dubbed “Blindsight,” the experimental brain implant gained clearance from the US Food and Drug Administration to participate in the voluntary program.

Elon Musk's Blindsight brain implant has achieved a major milestone. It's now being worn by Geordi La Forge. No wait, it's actually been awarded Breakthrough Device Designation by the FDA. But to celebrate,

Elon Musk's Neuralink has received FDA clearance for its experimental Blindsight device, designed to restore vision by targeting the brain's visual cortex.